The low prevalence of the coloboma phenotype in our medaka model can be explained as a result of both, the mosaic organism generated upon injection of the CRISPR/Cas9 system and the non–cell autonomous effect of the secreted ADAMTS16 protease. The gene discussed is ADAMTS16; the disease is coloboma.